Durvalumab Is Not Superior to Cetuximab in Head, Neck Cancer ...Middle East

Durvalumab did not improve outcomes compared with cetuximab in patients with head and neck squamous cell carcinoma who are ineligible for cisplatin, new findings indicate. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Durvalumab Is Not Superior to Cetuximab in Head, Neck Cancer )

Also on site :

• 205 Funny Dares That Will Embarrass Your Whole Crew
• I Tried Pvolve—Here's My Honest Review
• Firefighters save baby after he turns purple; “The worst night of our lives”